Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.

Higher antigliadin antibodies are linked to more severe alopecia areata, suggesting screening for celiac disease in these patients.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Higher antigliadin antibody levels are linked to alopecia areata severity.

Differences in growth factors in platelet-rich plasma therapy for hair loss can vary between patients and can be influenced by the devices used, possibly leading to inconsistent results.

HSP90 and lamin A/C are crucial for hair growth and could be targets for treating hair loss.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

People with alopecia areata often have lower vitamin D levels than healthy people.

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

Interleukin-6 may play a role in causing alopecia areata.

Macrophages help activate hair follicle stem cells, affecting hair growth and skin repair.

Manipulating the catagen and telogen phases of hair growth could lead to treatments for hair disorders.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Macrophages are vital for skin healing, hair growth, salt balance, and cancer defense.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

COVID-19 infection may trigger alopecia areata in some patients.

Different markers are found in stem cells of the scalp's hair follicle bulge and the surrounding skin.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

COVID-19 increased alopecia areata relapses due to inflammation and stress.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Many elderly women experience unwanted facial hair and various hair loss conditions, with treatments available for each condition.

Double-stranded RNA causes inflammation in hair follicle cells, which may help understand and treat alopecia areata.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.